Kayne Anderson Rudnick Investment Management’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1
Closed -$1K 581
2020
Q4
$1K Buy
+1
New +$634 ﹤0.01% 581
2020
Q1
Sell
-2
Closed -$2K 618
2019
Q4
$2K Sell
2
-9,551
-100% -$10.4M ﹤0.01% 551
2019
Q3
$11.4M Buy
9,553
+2,233
+31% +$3.41M 0.06% 173
2019
Q2
$12.1M Buy
7,320
+321
+5% +$555K 0.06% 162
2019
Q1
$14.3M Buy
6,999
+1,020
+17% +$1.8M 0.08% 141
2018
Q4
$7.68M Sell
5,979
-877
-13% -$1.35M 0.05% 175
2018
Q3
$13M Buy
6,856
+50
+0.7% +$103K 0.08% 156
2018
Q2
$13.8M Buy
6,806
+270
+4% +$615K 0.09% 150
2018
Q1
$14.5M Buy
+6,536
New +$16.6M 0.11% 143

Other funds holding BLUE

Kayne Anderson Rudnick Investment Management's BLUE Position: Q1 2021 in Review

Kayne Anderson Rudnick Investment Management sold out of bluebird bio (BLUE) in Q1 2021, closing a stake of 1 share — an estimated $1K sold.

Kayne Anderson Rudnick Investment Management first reported a position in BLUE in Q1 2018 and held it in 9 quarters. The position peaked at $14.5M in Q1 2018. 229 funds tracked by Wall St. Rank hold BLUE as of Q1 2021.

  • Kayne Anderson Rudnick Investment Management reported no remaining bluebird bio position as of Q1 2021 after selling out during the quarter.
  • Kayne Anderson Rudnick Investment Management sold 1 bluebird bio share in Q1 2021, an estimated $1K.
  • Kayne Anderson Rudnick Investment Management first reported a position in bluebird bio in Q1 2018 and held it in 9 quarters.
  • Kayne Anderson Rudnick Investment Management's bluebird bio position peaked at $14.5M in Q1 2018.
  • 229 funds tracked by Wall St. Rank held bluebird bio as of Q1 2021.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q1 2021, filed 17 May 2021.